142 related articles for article (PubMed ID: 12072182)
1. Assay of caspase activation in situ combined with probing plasma membrane integrity to detect three distinct stages of apoptosis.
Smolewski P; Grabarek J; Halicka HD; Darzynkiewicz Z
J Immunol Methods; 2002 Jul; 265(1-2):111-21. PubMed ID: 12072182
[TBL] [Abstract][Full Text] [Related]
2. Interactions of fluorochrome-labeled caspase inhibitors with apoptotic cells: a caution in data interpretation.
Pozarowski P; Huang X; Halicka DH; Lee B; Johnson G; Darzynkiewicz Z
Cytometry A; 2003 Sep; 55(1):50-60. PubMed ID: 12938188
[TBL] [Abstract][Full Text] [Related]
3. Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation.
Bedner E; Smolewski P; Amstad P; Darzynkiewicz Z
Exp Cell Res; 2000 Aug; 259(1):308-13. PubMed ID: 10942603
[TBL] [Abstract][Full Text] [Related]
4. Detection of caspases activation by fluorochrome-labeled inhibitors: Multiparameter analysis by laser scanning cytometry.
Smolewski P; Bedner E; Du L; Hsieh TC; Wu JM; Phelps DJ; Darzynkiewicz Z
Cytometry; 2001 May; 44(1):73-82. PubMed ID: 11309811
[TBL] [Abstract][Full Text] [Related]
5. Exposure of cells to static magnetic field accelerates loss of integrity of plasma membrane during apoptosis.
Teodori L; Grabarek J; Smolewski P; Ghibelli L; Bergamaschi A; De Nicola M; Darzynkiewicz Z
Cytometry; 2002 Nov; 49(3):113-8. PubMed ID: 12442311
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic cell death kinetics in vitro depend on the cell types and the inducers used.
Wolbers F; Buijtenhuijs P; Haanen C; Vermes I
Apoptosis; 2004 May; 9(3):385-92. PubMed ID: 15258471
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of HL-60 cell entry to apoptosis during treatment with TNF-alpha or camptothecin assayed by the stathmo-apoptosis method.
Smolewski P; Grabarek J; Lee BW; Johnson GL; Darzynkiewicz Z
Cytometry; 2002 Mar; 47(3):143-9. PubMed ID: 11891718
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB inhibitor sesquiterpene parthenolide induces concurrently atypical apoptosis and cell necrosis: difficulties in identification of dead cells in such cultures.
Pozarowski P; Halicka DH; Darzynkiewicz Z
Cytometry A; 2003 Aug; 54(2):118-24. PubMed ID: 12879458
[TBL] [Abstract][Full Text] [Related]
9. Fluorochrome-Labeled Inhibitors of Caspases: Expedient In Vitro and In Vivo Markers of Apoptotic Cells for Rapid Cytometric Analysis.
Darzynkiewicz Z; Zhao H; Dorota Halicka H; Pozarowski P; Lee B
Methods Mol Biol; 2017; 1644():61-73. PubMed ID: 28710753
[TBL] [Abstract][Full Text] [Related]
10. Detection of caspase activation in situ by fluorochrome-labeled caspase inhibitors.
Amstad PA; Yu G; Johnson GL; Lee BW; Dhawan S; Phelps DJ
Biotechniques; 2001 Sep; 31(3):608-10, 612, 614, passim. PubMed ID: 11570504
[TBL] [Abstract][Full Text] [Related]
11. In situ activation of caspases and serine proteases during apoptosis detected by affinity labeling their enzyme active centers with fluorochrome-tagged inhibitors.
Grabarek J; Darzynkiewicz Z
Exp Hematol; 2002 Sep; 30(9):982-9. PubMed ID: 12225789
[TBL] [Abstract][Full Text] [Related]
12. Fluorochrome-labeled inhibitors of caspases: convenient in vitro and in vivo markers of apoptotic cells for cytometric analysis.
Darzynkiewicz Z; Pozarowski P; Lee BW; Johnson GL
Methods Mol Biol; 2011; 682():103-14. PubMed ID: 21057924
[TBL] [Abstract][Full Text] [Related]
13. Use of fluorescently labeled caspase inhibitors as affinity labels to detect activated caspases.
Grabarek J; Amstad P; Darzynkiewicz Z
Hum Cell; 2002 Mar; 15(1):1-12. PubMed ID: 12126059
[TBL] [Abstract][Full Text] [Related]
14. Stathmo-apoptosis: arresting apoptosis by fluorochrome-labeled inhibitor of caspases.
Smolewski P; Grabarek J; Phelps DJ; Darzynkiewicz Z
Int J Oncol; 2001 Oct; 19(4):657-63. PubMed ID: 11562738
[TBL] [Abstract][Full Text] [Related]
15. Activation of chymotrypsin-like serine protease(s) during apoptosis detected by affinity-labeling of the enzymatic center with fluoresceinated inhibitor.
Grabarek J; Dragan M; Lee BW; Johnson GL; Darzynkiewicz Z
Int J Oncol; 2002 Feb; 20(2):225-33. PubMed ID: 11788882
[TBL] [Abstract][Full Text] [Related]
16. Intracellular determination of activated caspases (IDAC) by flow cytometry using a pancaspase inhibitor labeled with FITC.
Jayaraman S
Cytometry A; 2003 Dec; 56(2):104-12. PubMed ID: 14608638
[TBL] [Abstract][Full Text] [Related]
17. Labeling of apoptotic JURL-MK1 cells by fluorescent caspase-3 inhibitor FAM-DEVD-fmk occurs mainly at site(s) different from caspase-3 active site.
Kuzelová K; Grebenová D; Hrkal Z
Cytometry A; 2007 Aug; 71(8):605-11. PubMed ID: 17549763
[TBL] [Abstract][Full Text] [Related]
18. Sequential activation of caspases and serine proteases (serpases) during apoptosis.
Grabarek J; Du L; Johnson GL; Lee BW; Phelps DJ; Darzynkiewicz Z
Cell Cycle; 2002; 1(2):124-31. PubMed ID: 12429921
[TBL] [Abstract][Full Text] [Related]
19. Detection of caspases activation in situ by fluorochrome-labeled inhibitors of caspases (FLICA).
Darzynkiewicz Z; Bedner E; Smolewski P; Lee BW; Johnson GL
Methods Mol Biol; 2002; 203():289-99. PubMed ID: 12073450
[No Abstract] [Full Text] [Related]
20. Activation of caspases and serine proteases during apoptosis induced by onconase (Ranpirnase).
Grabarek J; Ardelt B; Du L; Darzynkiewicz Z
Exp Cell Res; 2002 Aug; 278(1):61-71. PubMed ID: 12126958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
